<DOC>
	<DOCNO>NCT01836679</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Chidamide combine paclitaxel carboplatin patient advance non-small-cell lung cancer .</brief_summary>
	<brief_title>Chidamide Combination With Carboplatin Paclitaxel Advanced Non-small Cell Lung Cancer</brief_title>
	<detailed_description>The study evaluate efficacy include progression free survival ( PFS ) , PFS 6 month , objective response rate , duration response rate , overall survival time progression , safety include adverse event , vital sign , laboratory test , treatment chidamide plus paclitaxel carboplatin patient advance non small cell lung cancer .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Patients histology cytology confirm nonsmallcell lung cancer , stage IIIb IV . Newly diagnose relapse surgery receive systemic drug therapy.Adjuvant chemotherapy surgery complete one year study entry . Aged 18~75 year Epidermal growth factor receptor ( EGFR ) mutation negative EGFR status unknown With least one measurable lesion White blood cell count≥4×10^9/L , platelet count≥100×10^9/L hemoglobin≥11g/L Life expectancy ＞3 month Eastern Cooperative Oncology Group performance status ≤1 study entry Women childbearing age pregnancy test negative would like conduct birth control study Have sign informed consent Patients clinically significant correct QT interval prolongation , ventricular tachycardia , auricular fibrillation , ≥Grade 2 sinoauricular heartblock , ≥Grade 3 atrioventricular block , myocardial infarction within one year , congestive heart failure , patient symptomatic coronary disease need treat drug The size fluid area detect cardiac ultrasonography cavum pericardium ≥10mm diastolic period Organ transplant patient Patients active bleed new thrombotic disease Patients body temperature ＞38.5℃ 3 day Total bilirubin ＞1.5 fold upper limit normal ( ULN ) , ALT/AST＞1.5 fold ULN serum creatine ＞1.5 fold ULN Patients symptomatic brainmetastasis Pregnant lactate woman Patients mental disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Chidamide , lung cancer</keyword>
</DOC>